This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989 Dec:4 Suppl 4:42-6.

Bone marrow transplantation for neuroblastoma: a review of 509 cases. EBMT Group

G Dini¹, T Philip, O Hartmann, R Pinkerton, F Chauvin, A Garaventa, E Lanino, S Dallorso

Affiliations

PMID: 2697436

Review

Bone marrow transplantation for neuroblastoma: a review of 509 cases. EBMT Group

G Dini et al. Bone Marrow Transplant. 1989 Dec.

. 1989 Dec:4 Suppl 4:42-6.

Authors

G Dini¹, T Philip, O Hartmann, R Pinkerton, F Chauvin, A Garaventa, E Lanino, S Dallorso

Affiliation

¹ Istituto Giannina Gaslini (IGG), Genova, Italy.

PMID: 2697436

No abstract available

PubMed Disclaimer

Similar articles

Unpurged ABMT for neuroblastoma: AIEOP-BMT experience.
Dini G, Lanino E, Garaventa A, Paolucci P, Amici A, Locatelli F, Colleselli P, Boni L, Dallorso S, Abla O, et al. Dini G, et al. Bone Marrow Transplant. 1991;7 Suppl 2:92. Bone Marrow Transplant. 1991. PMID: 1878740 Clinical Trial. No abstract available.
Intensification of induction prior to intensification of consolidation and bone marrow rescue in disseminated neuroblastoma.
Paolucci P, Mancini AF, Rosito P, Vecchi V, Vivarelli F, Granchi D, Calzolari P, Paolucci G. Paolucci P, et al. Bone Marrow Transplant. 1989 Dec;4 Suppl 4:151-2. Bone Marrow Transplant. 1989. PMID: 2697429 Clinical Trial. No abstract available.
Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
Seeger RC, Villablanca JG, Matthay KK, Harris R, Moss TJ, Feig SA, Selch M, Ramsay N, Reynolds CP. Seeger RC, et al. Prog Clin Biol Res. 1991;366:527-33. Prog Clin Biol Res. 1991. PMID: 2068169 Clinical Trial. No abstract available.
Autotransplants for neuroblastoma.
Kamani NR. Kamani NR. Bone Marrow Transplant. 1996 Mar;17(3):301-4. Bone Marrow Transplant. 1996. PMID: 8704677 Review. No abstract available.
Biology and therapy of childhood acute lymphoblastic leukemia.
Rivera GK, Crist WM, Sallan SE. Rivera GK, et al. Rev Invest Clin. 1994 Apr;Suppl:26-33. Rev Invest Clin. 1994. PMID: 7886304 Review. No abstract available.

See all similar articles

Cited by

Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review.
Mora J. Mora J. Cancers (Basel). 2022 May 24;14(11):2572. doi: 10.3390/cancers14112572. Cancers (Basel). 2022. PMID: 35681553 Free PMC article. Review.
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.
Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG. Matthay KK, et al. J Clin Oncol. 2009 Mar 1;27(7):1007-13. doi: 10.1200/JCO.2007.13.8925. Epub 2009 Jan 26. J Clin Oncol. 2009. PMID: 19171716 Free PMC article. Clinical Trial.
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B, Kremer LC, van Dalen EC. Yalçin B, et al. Cochrane Database Syst Rev. 2015 Oct 5;2015(10):CD006301. doi: 10.1002/14651858.CD006301.pub4. Cochrane Database Syst Rev. 2015. PMID: 26436598 Free PMC article.
Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report.
Mora J, Castañeda A, Gorostegui M, Varo A, Perez-Jaume S, Simao M, Muñoz JP, Garraus M, Larrosa C, Salvador N, Lavarino C, Krauel L, Mañe S. Mora J, et al. Cancers (Basel). 2023 Apr 28;15(9):2535. doi: 10.3390/cancers15092535. Cancers (Basel). 2023. PMID: 37174002 Free PMC article.
Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.
Wang H, Sun R, Chi Z, Li S, Hao L. Wang H, et al. Mol Cell Biochem. 2017 Sep;433(1-2):1-12. doi: 10.1007/s11010-017-3011-3. Epub 2017 Apr 5. Mol Cell Biochem. 2017. PMID: 28382490

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information